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Introduction
Lipoprotein (a) (Lp (a)) is a cholesterol-rich lipoprotein in blood serum with electrophoretic pre-ß-mobility (1) and a lipid composition similar to low density lipoproteins (LDL) (2) . Like LDL, Lp (a) contains mainly apolipoprotein B (62%), but also Lp (a) apolipoprotein (20%) and albumin (15%) (3) . Unlike LDL, Lp(a) floats in a higher density ränge (1.055-1.110 kg/l) (4) and has a higher proportion of carbohydrate (3) . Lp (a) is present in almost all individuals, although the concentrations can vary quite considerably (5) .
Various projects agree in their findings that individuals with raised Lp(a) values run a higher risk of developing coronary heart disease prematurely (6) (7) (8) . Lp (a) does not correlate significantly with other risk factors such äs age, sex, cholesterol, triglycerides (l, 8, 9) or cigarette smoking (10) . Results of epidemiological studies on the correlation of Lp(a) values and premature development of coronary heart disease have not been available until now.
This present study reports the first results of our epidemiological study on the distribution of Lp (a) values in Company employees in Westfalia, and the correlation of Lp (a) values to risk factors for coronary heart disease in these subjects.
Lipoprotein (a) assay
For the determination of lipoprotein (a) (Lp(a)) in blood serum, one dimensional Laurell immunelectrophoresis was used (12) . As antibody we used Antihuman Lp(a) from sheep (Immuno Comp., D-6900 Heidelberg, order no. 4845005).
As Standard reference Human Lp(a) (Immuno Comp. D^6900 Heidelberg, order no. 4395005) was used.
Analysis of HDL components
HD L cholesterol was enzymatically analysed using the CHOD-PAP method (Boehringer Mannheim, test cornbination no. 187313), äs described elsewhere (13) . Determination of HDL phosphatidyl choline was carried out äs enzymatic colour test using the centrifugal analyser Cobas Bio (Hoffmann La Röche). This method is described in detail elsewhere (14) .
Analysis of LDL components
LDL cholesterol and LDL apolipoprotein B were determined following selective precipitation pf, VLDL with phosphotungstic acid/MgCb äs described in detail elsewhere
Statisücs
Comparisons of frequencies were done by the x 2 -test. To test whether two distributions are equal, we used the Mann-Whitney IMest, and for multiple comparisons the test by Nemenyi. We calculated with Kendall's instead of Spearman's rank correlation coefficients because of the high number of tied ranks.
The significance level was set at 0.05.
Materials and Methods

Sample material
As test material we used fresh serum from the test series "Prospective epidemiological study of Company employees in Westfalia" (11) .
Methods
Analyses of cholesterol, triglycerides, glucojse and uric acid were performed with the SMAC Analyser (Technicon GmbH, Bad Vü-bel, FRG) äs described elsewhere (11) .
Results
Description of the test group
Lp(a) concentrations in serurn were determined in 987 male and 477 female Company employees in Westfalia. The average age of the men was 42.1 years (± 10.8 years), of the wome» 36,4 years (i 13.2 years), age ränge: 17 to 70 years. The medium Broca index for men was 104.0% ± 13.3%, with a •ränge of 72% to 161%, for women 99.0% ± 16.6%, with a ränge of 69% to 165%; 30.7% of the men were smokers with an average consümption of 18. 
Distribution of Lp (a) concentrations
For both sexes Lp(a) values had a similar high skewed distribution (tab. 3). In 14% of men and 12% of women values were below 0.02 g/l; 23% of men and 19% of women had values of 0.02 g/l, and 13% of men and 10% of women had values of 0.03 g/1. Only approx. 25% of all men and women had values >0.10 g/l. In both sexes, the proportion of subjects with Lp(a) concentrations of >0.25 g/l was 10%, 5% hadLp(a) concentrations >0.37 g/l. 6.5% f men and 6.1% of women had Lp(a) values >0.30 g/i.
Correlation of Lp (a) values to age
Whereas in men a correlation to age could not be statistically proven, there.was a pronounced positive correlatio0 of age to Lp (a) values in women (r = 0.12, p < 0.001), with a sudden increase in values for 40-50 year olds, i.e. approx. at the onset of the menopause. The medium value of Lp (a) in premenopausal women was 0.094 ± 0.129 g/l, in postmenopausal women it was 0.131 ± 0.171 g/l (p < 0.001). The proportion of subjects with raised Lp(a) values (>0.30 g/l) increased with the onset of the menopause frofn 4.1% to 11.3% (p < 0.01). Taking the Lp (a) concentration äs an independent factor, the prevalence of the tested risk factors was cornpared in subjects with Lp(a) values >0.30 g/l (always mentioned first) and in those with Lp (a) values < = 0.30 g/l; the following results were obtained: The proportion of men vSith hypoalphalipoproteinaemia was significantly raised (p < 0.01) (28.1% äs opposed to 14.3%; 15.6% äs opposed to 5.3% when combined with hypertriglyceridaemia).
In women the proportion of subjects with hypercholesterolaemia was 27.6% in the group with Lp(a) values >0.30 g/l, whereas only 7.6% of the remaining subjects showed hypercholesterolaemia. The corresponding values for hyperbetalipoproteinaemia were 24.1% compared to 5.5%. In both cases the proportion of affected subjects is significantly increased (p < 0.001). 
Lp (a) values in hyperlipidaemic employees
The proportion of female subjects with raised Lp A general increase of Lp (a) values was, however, not observed in these individuals (median 0.02 g/1). Corresponding calculations for women were not feasible due to the low prevalence of hypertriglyceridaemia.
Discussion
An essential characteristic of Lp (a) lipoprotein is its markedly skewed distribution in the population. This has been shown by several authors (l, 5, 8, 16-18) and confirmed by us. The majority of the population obviously has relatively low Lp(a) concentrations, and higher Lp(a) values are found in only a few individuals. Individuais with Lp(a) values >0.30 g/l show corresponding "sinking pre-beta bands" in electrophoresis (19) . It has been shown that the sinking pre-beta bands are passed on by autosomal dominant inheritance (19) (20) (21) . In our tests, the median value for Lp(a) was about 0.04 g/ for men and 0.05 g/l for women; the 90th percentile was at 0. Various research projects agree in their finding that patients with coronary heart disease have obviously higher Lp(a) Values than healthy controls (6-8). Kostner et al. established a cut-off point at 0.3 g/l, above whieh an increased risk of coronary heart disease can be assumed (8) . It has also been shown repeatedly, that Lp(a) has no bearing on known coronary risk factors, such äs age, chplesterol, triglycerides (l, 8, 9) or cigarette consumption (10) . However, the correlation of Lp (a) value and risk factors has so far only been tested on a relatively small scale in predominantly clinical orientated research, and to our knowledge, there are äs yet no prospective epidemiological studies with larger numbers of subjects. Contrary to data published so far, we found a pronounced positive correlation of age to Lp (a) values in women. The division of the subjects into age groups showed, however, that the correlation results from a sharp increase in Lp(a) in 40-50 year old women, and is hence possibly related to the onset of the menopause. Since in >40-50 year old women LDL cholesterol values are also enhanced (22) and since in our results Lp (a) values are positively correlated with total cholesterol levels äs well äs with LDL cholesterol values one might speculate that the increase in Lp (a) values in post-menopausal women may be related to a common catabolic pathway of LDL and Lp (a). Based on the observation that the hepatic B, E receptor can be stimulated by pharmacological doses of oestrogen (23), changes in the plasma levels of LDL in postmenopausal women may be caused by reciprocal changes in the activity of the hepatic B, E receptor. At present, however, there are contradictory results with regard to the role of B, E receptörs in the metabolism of Lp(a). According to findings of Floren et al. (24) , Lp(a) was taken up mainly by the LDL receptor pathway, while according to the results of Martmann-Moe & Berg (25) , Lp(a) was taken up independently of the LDL receptor pathway. Another indication for a different catabolic pathway of LDL and Lp (a) is the observation that in hypercholesterolaemic patients the application of cholestyramine only resulted in a reduction of the plasma LDL level without any change of the Lp(a) level (26) .
Research by Walton et al. (16) or Kostner et al. (8) shows that individuals with hyperlipidaemia frequently have higher Lp (a) values than normolipidaemics. These observations were confirmed in our research: in subjects with hypertriglyceridaemia and hypoalphalipoproteinaemia there was a relatively higher proportion of subjects with Lp (a) values >0.30 g/l cornpared to normolipidaemics.
